Company intelligence / Profile preview

Modra Pharmaceuticals

Amsterdam, Netherlandsmodrapharmaceuticals.com ↗

Ownership: Private
Employees: ~8
Development stage: Phase 2

Overview

Modra's lead product ModraDoc006/r has completed Phase IIb trials in metastatic prostate cancer. The company has shown promising results in Phase I studies and is advancing its pipeline of oral taxane formulations.

Therapeutic areas: Oncology
Modalities: Small moleculesoral taxane formulations
Industry: Biotech

Drug pipeline

7 assets

ModraDoc006

6 more assets in the full pipeline.

Request access →

Beyond the preview

Go deeper on Modra Pharmaceuticals.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Modra Pharmaceuticals.

Explore the full profile